Boston Scientific Corp · Healthcare
Boston Scientific Corp (BSX) is a stock traded in US markets in the Healthcare sector. P/E 17.81, P/B 2.55, ROE 15.52% and dividend yield not disclosed. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
The source returned no recent distributions for this asset.
Financial statements are not available for this asset yet.
The current price of BSX is $43.92.
The P/E ratio of BSX is 17.81, meaning investors pay 17.81 times earnings per share.
The P/B of BSX is 2.55, meaning the stock trades at 2.55 times its book value per share.
The ROE (Return on Equity) of BSX is 15.52%, meaning the company generates 15.52% of profit for every unit of shareholders' equity.
The market capitalization of BSX is US$ 63.7 B.
The net profit margin of BSX is 17.50%, meaning the company keeps 17.50% of revenue as profit.
The debt-to-equity ratio of BSX is 0.51, meaning the company has 0.51 units of debt for each unit of equity.
BSX operates in the Healthcare sector.